Study population
All subjects are adult males (aged 20-40 years) with normal weight
according to the a body mass index BMI. The subjects who have atopic
constitution or asthma and/or known allergy for Favipiravir and/or any
of the excipients of the products and who have any history or presence
of clinical relevance of cardiovascular, neurological, musculoskeletal,
haematological, hepatic, gastrointestinal, renal, pulmonary,
endocrinological, metabolism were excluded from the study. The inclusion
and exclusion criteria were established clearly together with the
reasons for withdrawal from the study. The subjects who were willing to
participate in the clinical trial signed the informed consent form on
their own freewill and understood that they could withdraw from the
study anytime without specifying any reason.